Division of Critical Care Medicine, Department of Medicine, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY.
Department of Pharmacy, Massachusetts General Hospital, Boston, MA.
Crit Care Med. 2020 Oct;48(10):1436-1444. doi: 10.1097/CCM.0000000000004429.
To characterize the association between the use of physiologic assessment (central venous pressure, pulmonary artery occlusion pressure, stroke volume variation, pulse pressure variation, passive leg raise test, and critical care ultrasound) with fluid and vasopressor administration 24 hours after shock onset and with in-hospital mortality.
Multicenter prospective cohort study between September 2017 and February 2018.
Thirty-four hospitals in the United States and Jordan.
Consecutive adult patients requiring admission to the ICU with systolic blood pressure less than or equal to 90 mm Hg, mean arterial blood pressure less than or equal to 65 mm Hg, or need for vasopressor.
None.
Of 1,639 patients enrolled, 39% had physiologic assessments. Use of physiologic assessment was not associated with cumulative fluid administered within 24 hours of shock onset, after accounting for baseline characteristics, etiology and location of shock, ICU types, Acute Physiology and Chronic Health Evaluation III, and hospital (beta coefficient, 0.04; 95% CI, -0.07 to 0.15). In multivariate analysis, the use of physiologic assessment was associated with a higher likelihood of vasopressor use (adjusted odds ratio, 1.98; 95% CI, 1.45-2.71) and higher 24-hour cumulative vasopressor dosing as norepinephrine equivalent (beta coefficient, 0.37; 95% CI, 0.19-0.55). The use of vasopressor was associated with increased odds of in-hospital mortality (adjusted odds ratio, 1.88; 95% CI, 1.27-2.78). In-hospital mortality was not associated with the use of physiologic assessment (adjusted odds ratio, 0.86; 95% CI, 0.63-1.18).
The use of physiologic assessment in the 24 hours after shock onset is associated with increased use of vasopressor but not with fluid administration.
描述在休克发生后 24 小时内使用生理评估(中心静脉压、肺动脉嵌压、每搏量变异、脉压变异、被动抬腿试验和重症超声)与液体和血管加压药的使用以及院内死亡率之间的关系。
2017 年 9 月至 2018 年 2 月期间进行的多中心前瞻性队列研究。
美国和约旦的 34 家医院。
连续纳入的因收缩压≤90mmHg、平均动脉压≤65mmHg 或需要血管加压药而需要入住 ICU 的成年患者。
无。
在纳入的 1639 例患者中,有 39%接受了生理评估。在考虑了基线特征、休克的病因和部位、ICU 类型、急性生理学和慢性健康评估 III 以及医院后,生理评估的使用与休克发生后 24 小时内累计输液量无关(β系数,0.04;95%置信区间,-0.07 至 0.15)。多变量分析显示,生理评估的使用与血管加压药使用的可能性增加相关(调整后的优势比,1.98;95%置信区间,1.45-2.71),并且以去甲肾上腺素当量表示的 24 小时累积血管加压药剂量更高(β系数,0.37;95%置信区间,0.19-0.55)。使用血管加压药与院内死亡率增加相关(调整后的优势比,1.88;95%置信区间,1.27-2.78)。生理评估的使用与院内死亡率无关(调整后的优势比,0.86;95%置信区间,0.63-1.18)。
在休克发生后 24 小时内使用生理评估与血管加压药的使用增加有关,但与液体管理无关。